Clinical studies recruiting near Raleigh

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Duke Cancer Center Raleigh · Pfizer · NCT07028853 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Raleigh Neurology Associates · Takeda · NCT06747351 Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Phase N/A · Duke Women's Cancer Care Raleigh · Duke University · NCT04085029 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Eximia Research - NC, LLC · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Duke Cancer Center Raleigh · NRG Oncology · NCT05624996 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Accellacare of Raleigh · Amgen · NCT07037433 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 145 · Locus Biosciences · NCT05488340 Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
NA · NC Heart& Vascular · Rijnstate Hospital · NCT05484115 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · WakeMed Raleigh Campus · Eli Lilly and Company · NCT06890598 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 SELUTION4BTK Trial
NA · NC Heart and Vascular Research, LLC · M.A. Med Alliance S.A. · NCT05055297 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Pfizer · NCT05895786 An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract
Phase 3 · M3 Wake Research · Neuvosyn Laboratories, LLC · NCT07747103 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · UNC Health Cancer Care Raleigh · NRG Oncology · NCT05174169 The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of U
NA · WakeMed Health & Hospitals · University of Washington · NCT06740266 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 12085 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · Accellacare of Raleigh · Amgen · NCT07575399 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Raleigh Neurology Associates- Site Number : 8400043 · Sanofi · NCT06290128 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Associated Urologists of North Carolina · Janssen Research & Development, LLC · NCT06319820 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Duke Women's Cancer Care Raleigh · Alliance for Clinical Trials in Oncology · NCT06876714 Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Phase 2 · WakeMed · Basking Biosciences, Inc. · NCT06226805 SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NA · WakeMed · VenoStent · NCT06001827 A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · WakeMed Children's - Pediatric Endocrinology - North Raleigh · BioMarin Pharmaceutical · NCT06309979 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Associated Urologists of North Carolina · Dendreon · NCT06134232 A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NA · Associated Urologists of North Carolina · Rivermark Medical · NCT06849258 Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NA · Unified Women's Clinical Research-Raleigh · Coologics, Inc · NCT06983041 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · WakeMed Raleigh Campus ( Site 3214) · Merck Sharp & Dohme LLC · NCT07513376 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Duke Women's Cancer Care Raleigh · Alliance for Clinical Trials in Oncology · NCT04242095

Look up another city

Look up another condition